Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient - Wikidata - wikimedia - TriplyDB

Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient

Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient

http://www.wikidata.org/entity/Q34871994

about

HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy.

P2860

Q36428308-E041522C-13EE-4044-8832-A21A2FC739DA Q39315703-3207B91D-87C7-4D74-AA05-72DB93E7384C

P2860

Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient

http://www.wikidata.org/entity/Q34871994

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Persistent production of an in ...... viral DNA in a treated patient

@ast

Persistent production of an in ...... viral DNA in a treated patient

@en

Persistent production of an in ...... viral DNA in a treated patient

@nl

type

label

Persistent production of an in ...... viral DNA in a treated patient

@ast

Persistent production of an in ...... viral DNA in a treated patient

@en

Persistent production of an in ...... viral DNA in a treated patient

@nl

prefLabel

Persistent production of an in ...... viral DNA in a treated patient

@ast

Persistent production of an in ...... viral DNA in a treated patient

@en

Persistent production of an in ...... viral DNA in a treated patient

@nl

P1433

Q34871994-4FC9BAFE-6AC1-44E1-8066-1E1661E1F559

P1476

Q34871994-539D7FEB-1687-4C7D-9D41-C765B82851DB

P2093

Q34871994-0919B17C-576F-4E56-A743-8EE1ABFC538F

Q34871994-25876768-25FB-4AE6-9ACF-5D1AE0BE05C5

Q34871994-31344306-FAA5-40D5-9D65-DBF8D6ED3163

Q34871994-80DA5DAE-D699-4CE6-AF0C-14DED232FCC3

Q34871994-8EE9C418-273B-4DCD-904B-84AF90674D79

Q34871994-E8BF7CCB-F7E0-43F7-B2D0-B63077E7D93E

Q34871994-EDB578D8-D92C-4C61-82BC-CCFEC5FDF8C4

Q34871994-F7045BBE-B4E9-4E8A-907B-6313F3DA5A6A

P2860

Q34871994-085DB5EB-A4BD-4F3F-AA75-1268490B42C6

Q34871994-0F7FA8BC-730E-426E-9A33-EEE3ED9A91A9

Q34871994-1694C996-562D-4051-9F84-823D3C017019

Q34871994-1B92EF3B-3E16-417A-AABB-164EFBE51EB0

Q34871994-223ECF7F-F1DF-4E23-8C41-E19FF4B7B263

Q34871994-2736265C-2058-4787-AE3B-2074EA236EDC

Q34871994-278C0DBC-87E2-4F8F-AAE0-AB6E90288D25

Q34871994-2C201406-1803-466F-95CD-76F6BD35C4FD

Q34871994-554C632B-CA39-4B61-8A28-36FD41B1CC94

Q34871994-590BFF03-3165-430F-ADCA-3C5B2D3F55DB

P304

Q34871994-9F38864E-9F61-4840-9114-4385CF10E662

P31

Q34871994-BAF672FF-564C-48BE-9562-9B53D85BC3AF

P356

Q34871994-15A78211-C1DD-47A0-BC85-EDAD6B77F3BE

P433

Q34871994-65458C95-00C6-438D-9983-41EAD262EEC8

P478

Q34871994-F12B916C-F32F-4C2B-A23F-FBD14DB903F2

P50

Q34871994-72E3D544-D085-4F9D-A1F9-64F9B947B46C

P577

Q34871994-F25BDDC5-F43E-4A0C-A270-BAAFA676CADA

P698

Q34871994-8B50479C-A5B0-480C-9A9B-ED6E2CB5D8A7

P932

Q34871994-97BE82A8-7D4F-493D-8DAB-BEFA05CDE2D0

P356

P1433

AIDS Research and Human Retroviruses

P1476

Persistent production of an in ...... viral DNA in a treated patient

@en

P2093

Christophe Ramière

http://www.w3.org/2001/XMLSchema#string

Corinne Ronfort

http://www.w3.org/2001/XMLSchema#string

Guillaume Monneret

http://www.w3.org/2001/XMLSchema#string

Jean-Claude Tardy

http://www.w3.org/2001/XMLSchema#string

Julien Saison

http://www.w3.org/2001/XMLSchema#string

Laurent Cotte

http://www.w3.org/2001/XMLSchema#string

Mary-Anne Trabaud

http://www.w3.org/2001/XMLSchema#string

Patrice André

http://www.w3.org/2001/XMLSchema#string

P2860

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

Anatomical basis of tolerance and immunity to intestinal antigens.

Structure-based modeling of the functional HIV-1 intasome and its inhibition

Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy

Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals.

The large intestine as a major reservoir for simian immunodeficiency virus in macaques with long-term, nonprogressing infection.

HIV-1 replication.

Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy

P304

142-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/AID.2014.0129

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25333615

http://www.w3.org/2001/XMLSchema#string

P932

4287311

http://www.w3.org/2001/XMLSchema#string